======= HS3ST3A1 =======
== Gene Information ==
* **Official Symbol**: HS3ST3A1
* **Official Name**: heparan sulfate-glucosamine 3-sulfotransferase 3A1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9955|9955]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y663|Q9Y663]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=HS3ST3A1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HS3ST3A1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/604057|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) to catalyze the transfer of a sulfo group to an N- unsubstituted glucosamine linked to a 2-O-sulfo iduronic acid unit on heparan sulfate. Catalyzes the O-sulfation of glucosamine in IdoUA2S-GlcNS and also in IdoUA2S-GlcNH2. The substrate-specific O-sulfation generates an enzyme-modified heparan sulfate which acts as a binding receptor to Herpes simplex virus-1 (HSV-1) and permits its entry. Unlike 3-OST-1, does not convert non- anticoagulant heparan sulfate to anticoagulant heparan sulfate. {ECO:0000269|PubMed:10520990}.
|Sulfotransfer 1|
|[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity|
|[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity|
|heparan sulfate sulfotransferase activity|
|heparan sulfate proteoglycan biosynthetic process|
|sulfotransferase activity|
|heparan sulfate proteoglycan metabolic process|
|proteoglycan biosynthetic process|
|proteoglycan metabolic process|
|glycosaminoglycan biosynthetic process|
|aminoglycan biosynthetic process|
|glycosaminoglycan metabolic process|
|aminoglycan metabolic process|
|glycoprotein biosynthetic process|
|glycoprotein metabolic process|
|carbohydrate derivative biosynthetic process|
|Golgi membrane|
|carbohydrate derivative metabolic process|
|organonitrogen compound biosynthetic process|
|cellular macromolecule biosynthetic process|
|macromolecule biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp59|UMK57 1μM R01 exp59]]|-2.43|
|[[:results:exp209|Deguelin 0.15μM R05 exp209]]|-1.93|
|[[:results:exp114|A-196 10μM R03 exp114]]|-1.76|
^Gene^Correlation^
|[[:human genes:h:hgc6.3|HGC6.3]]|0.516|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 7122
* **Expression level (log2 read counts)**: 0.5
{{:chemogenomics:nalm6 dist.png?nolink |}}